Additional 61,120 vials of Liposomal Amphotericin B allocated to states/UTs and central institutions: Gowda Read more
Investments in R&D, technology can make Indian pharma industry atma nirbhar in the next 2-3 years: Gowda Read more
Indian pharma industry will be among the first to develop and supply low cost vaccines for COVID-19: Gowda Read more